The Blog
-
Jul 08, 2024Nintedanib: A Multifaceted Tyrosine Kinase Inhibitor
READ MORE -
Jun 04, 2024Small Molecule Prodrugs: Current Status and Future Prospects
READ MORE -
May 28, 2024Things about small molecule covalent inhibitors
READ MORE -
May 16, 2024Advancements in CD73 Inhibitors: Pioneering Cancer Immunotherapy
READ MORE -
May 13, 2024Tukysa (Tucatinib): A Novel Treatment for HER2-Positive Breast Cancer
READ MORE -
Apr 30, 2024Advances in FGFR: Cancer targets, therapy, and signaling elucidation
READ MORE -
Apr 29, 2024Extracellular Protein Targeted Degradation (eTPD): Six Major Drug Discovery Patterns
READ MORE -
Nov 03, 2023Cholesterol-lowering Star – PCSK9 Inhibitors
READ MORE -
Oct 12, 2023The Efficacy and Safety of Immune Checkpoint Inhibitors in Treating Melanoma
READ MORE